TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States
- PMID: 31170384
- DOI: 10.1016/j.contraception.2019.05.013
TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States
Abstract
Objectives: To evaluate the safety, feasibility, and acceptability of a direct-to-patient telemedicine service that enabled people to obtain medical abortion without visiting an abortion provider in person.
Study design: We offered the service in five states. Each participant had a videoconference with a study clinician and had pre-treatment laboratory tests and ultrasound at facilities of her choice. If the participant was eligible for medical abortion, the clinician sent a package containing mifepristone, misoprostol, and instructions to her by mail. After taking the medications, the participant obtained follow-up tests and had a follow-up consultation with the clinician by telephone or videoconference to evaluate abortion completeness. The analysis was descriptive.
Results: Over 32 months, we conducted 433 study screenings and shipped 248 packages. The median interval between screening and mailing was 7 days (91st percentile 17 days), and no participant took the mifepristone at ≫71 days of gestation. We ascertained abortion outcomes of 190/248 package recipients (77%): 177/190 (93%) had complete abortion without a procedure. Of the 217/248 package recipients who provided meaningful follow-up data (88%), one was hospitalized for postoperative seizure and another for excessive bleeding, and 27 had other unscheduled clinical encounters, 12 of which resulted in no treatment. A total of 159/248 participants who received packages (64%) completed satisfaction questionnaires at study exit; all were satisfied with the service.
Conclusions: This direct-to-patient telemedicine abortion service was safe, effective, efficient, and satisfactory. The model has the potential to increase abortion access by enhancing the reach of providers and by offering people a new option for obtaining care conveniently and privately.
Implications: Provision of medical abortion by direct-to-patient telemedicine and mail has the potential to increase abortion access by increasing the reach of providers and by offering people the option of obtaining abortion care without an in-person visit to an abortion provider.
Keywords: Mail; Medical abortion; Telemedicine; United States.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment in
-
Telemedicine for medication abortion.Contraception. 2019 Nov;100(5):351-353. doi: 10.1016/j.contraception.2019.07.005. Epub 2019 Jul 26. Contraception. 2019. PMID: 31356771 No abstract available.
Similar articles
-
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.Contraception. 2021 Jul;104(1):43-48. doi: 10.1016/j.contraception.2021.03.019. Epub 2021 Mar 27. Contraception. 2021. PMID: 33781762 Free PMC article.
-
A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.Contraception. 2015 Sep;92(3):215-9. doi: 10.1016/j.contraception.2015.06.026. Epub 2015 Jul 2. Contraception. 2015. PMID: 26142620 Clinical Trial.
-
A direct-to-patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months.Aust N Z J Obstet Gynaecol. 2018 Jun;58(3):335-340. doi: 10.1111/ajo.12800. Epub 2018 Mar 30. Aust N Z J Obstet Gynaecol. 2018. PMID: 29603139
-
The mifepristone-misoprostol regimen for early medical abortion.Curr Womens Health Rep. 2001 Dec;1(3):184-90. Curr Womens Health Rep. 2001. PMID: 12112968 Review.
-
Abortion through telemedicine.Curr Opin Obstet Gynecol. 2018 Dec;30(6):394-399. doi: 10.1097/GCO.0000000000000498. Curr Opin Obstet Gynecol. 2018. PMID: 30399015 Review.
Cited by
-
Family medicine provision of online medication abortion in three US states during COVID-19.Contraception. 2021 Jul;104(1):54-60. doi: 10.1016/j.contraception.2021.04.026. Epub 2021 Apr 30. Contraception. 2021. PMID: 33939985 Free PMC article.
-
U.S. Abortion Care Providers' Perspectives on Self-Managed Abortion.Qual Health Res. 2022 Apr;32(5):788-799. doi: 10.1177/10497323221077296. Epub 2022 Mar 24. Qual Health Res. 2022. PMID: 35322703 Free PMC article.
-
Telemedicine for Family Planning: A Scoping Review.Obstet Gynecol Clin North Am. 2020 Jun;47(2):287-316. doi: 10.1016/j.ogc.2020.02.004. Epub 2020 Apr 29. Obstet Gynecol Clin North Am. 2020. PMID: 32451019 Free PMC article.
-
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.BJOG. 2021 Oct;128(11):1752-1761. doi: 10.1111/1471-0528.16813. Epub 2021 Jul 27. BJOG. 2021. PMID: 34138505 Free PMC article.
-
Addressing Structural Inequities, a Necessary Step Toward Ensuring Equitable Access to Telehealth for Medication Abortion Care During and Post COVID-19.Front Glob Womens Health. 2022 Mar 17;3:805767. doi: 10.3389/fgwh.2022.805767. eCollection 2022. Front Glob Womens Health. 2022. PMID: 35368993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical